Chapter 110: Drugs for Skin Conditions

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

You might think applying a topical lotion is like the safest thing in the world.

You know, a patient has a dry patch, you rub some moisturizer on it, and you're done.

Right, it feels very surface level, very harmless.

Exactly.

But what if I told you that putting a standard prescription cream on a baby and then just wrapping them in a normal everyday diaper could inadvertently cause life -threatening systemic toxicity and actually shut down their adrenal glands?

Yeah, I mean, it sounds completely impossible until you realize that the skin isn't just a physical barrier.

It is a highly permeable, biologically active doorway.

When we treat the skin, we are interacting with the body's largest organ.

And the drugs we apply to it can have profound systemic effects that reach far beyond the epidermis.

So if you are a nursing student gearing up for a pharmacology exam or stepping into your first clinical rotation, this is the exact mindset shift you need.

Absolutely.

Welcome to a custom -tailored deep dive into Chapter 110 of Lane's Pharmacology for Nursing Care.

We are tackling drugs for skin conditions today.

And our goal today is to translate this incredibly dense pharmacological material into, well, clear cause -and -effect clinical reasoning.

We want to understand the why and the how behind these drugs.

Right, so you aren't just memorizing lists, but actually understanding how to keep your patients safe.

Yeah.

Okay, let's unpack this.

Before you can even think about treating the skin, you have to understand the canvas you're painting on.

Yes, the anatomy.

Right.

Like, how does a drug physically get from the outside of the body to the inside?

Well, we have to start at the microscopic level.

The text maps out three distinct layers of the anatomy.

On the very outside, you have the epidermis.

And the deepest part of that epidermis is called the basal layer.

Okay.

It is highly mitotically active, meaning cells are constantly dividing and multiplying down there.

As they multiply, they push the older cells up toward the surface.

So they're kind of on an escalator.

Exactly.

And by the time those cells reach the top, they are dead, keratinized, and tightly packed together.

That rough, dead outer surface is the stratum corneum.

It's basically a microscopic brick wall.

That's a perfect way to visualize it.

Beneath that brick wall is the dermis.

This is your support system.

It houses your connective tissue, blood vessels, hair follicles, and sebaceous glands, which produce sebum.

Okay, got it.

And finally, below the dermis is the subcutaneous tissue, which is mostly fat for insulation.

So when you apply a topical drug, it has to navigate that entire anatomical gauntlet.

Which just sounds tough.

It is.

How well it penetrates depends entirely on the formulation or the vehicle that the drug is mixed into.

The textbook categorizes these largely by their oil to water ratio.

So going back to the brick wall analogy, if I have a drug in an ointment which is super thick, greasy, and has almost no water, what happens when I put that on the skin?

You are essentially wrapping that brick wall in plastic wrap.

Oh, wow.

Yeah.

Ointments create what we call occlusion.

They form an impermeable layer over the stratum corneum that prevents any water from evaporating.

So the water is just trapped.

Exactly.

The skin underneath swells with trapped moisture, and that waterlogged state physically forces the drug deep into the tissues.

Because of this, ointments yield the highest absorption rate of any formulation.

Which sounds fantastic for something like dry, scaly skin.

But that makes me wonder,

I mean, if ointments are the absolute best at forcing drugs into the body, why don't we just manufacture every single dermatologic drug as an ointment?

Because occlusion can quickly become dangerous.

Imagine a patient with a weeping, oozing wound, or a severe rash in a sweaty skin fold, like under the arms or the groin.

Right, areas that are already wet.

Exactly.

If you wrap that in a greasy occlusive ointment, you trap all that biological fluid in heat, that causes maceration.

The skin literally breaks down from being too waterlogged.

Oh, yuck.

Yeah, it's not good.

Worse, that breakdown destroys the barrier, and suddenly the drug absorption skyrockets to potentially toxic systemic levels.

So for those oozing or sweaty areas, what's the alternative?

You would want a cream, which is an emulsion of oil and water that allows some evaporation, or a lotion, which is mostly water -based.

Like a light mist that slides through the cracks and dries quickly.

That makes sense for hairy areas, too, where an ointment would just make a huge mess.

Right.

You also have alcohol -based gels that cool the skin as they evaporate, making them great for oily skin, and you have powders to reduce friction.

But one of the most fascinating vehicles is a paste.

Like what?

Think of an over -the -counter diaper rash product like Desitin.

It is a paste, which means it starts as a thick ointment, but it has a massive amount of powder mixed into it.

So the powder acts like, I don't know, tiny little ventilation shafts.

It breaks up the plastic wrap effect of the ointment.

Precisely.

The powder interrupts the occlusion, allowing the skin to breathe while still providing a thick protective barrier, which is why you can safely put a thick layer of Desitin under a tightly fastened diaper without waterlogging the baby's skin.

That is a brilliant bridge to our next topic.

Let's talk about the universal soothers topical glucocorticoids, or steroids.

If a patient comes in with an inflamed, incredibly itchy rash, this is usually the first line of defense, right?

Usually yes.

The primary therapeutic goal of topical steroids is to relieve inflammation and itching, and they do it exceptionally well by suppressing the immune response right at the site.

But as the comparative charts in your text show, these drugs are categorized by their relative potency.

They range from low potency, over -the -counter hydrocortisone, all the way up to super high potency agents like clobetisol propionate.

And as a nurse, you can't just casually rub clobetisol all over a patient.

What are the variables that dictate how much of that steroid actually makes it into the bloodstream?

Well, absorption increases significantly with prolonged use, or if you apply it to a very large surface area.

It also spikes if the skin is already broken or inflamed because the barrier is compromised.

Okay, that makes sense.

And circling back to our formulation principles, absorption multiplies if you cover the steroid with an occlusive dressing.

Wait a minute.

If occlusion forces the drug into the bloodstream, and earlier we said a diaper is basically a tight, warm, sealed environment,

isn't a diaper functioning as a giant occlusive dressing?

It absolutely is.

And this is a massive critical patient teaching moment.

If a parent applies a potent prescription steroid cream to an infant's severe diaper rash and then fastens a tight diaper over it, they are inadvertently hyperdosing that infant.

The occlusion traps the steroid, forces it deep into the highly vascularized dermis, and pushes it directly into systemic circulation.

What happens to a baby that absorbs that much steroid?

Systemically, exogenous steroids signal the body that it doesn't need to produce its own hormones anymore.

This causes profound adrenal suppression, and in children, it can lead to significant growth delay.

That is terrifying.

Yeah.

Even locally, highly potent steroids can cause thinning of the skin, stretch marks, and purpura, which are red spots from microscopic local hemorrhages.

So the nursing implication is strict apply in a thin film only where needed and be incredibly wary of what you cover it with.

Let's pivot from calming the skin down to actively peeling it off.

I want to talk about acne, which the text highlights as the most common dermatologic disease.

To treat it, we use keratolitics.

How do those work?

Well, keratolitics do exactly what the name implies.

They lies or break down keratin.

They promote the shedding of the stratum corneum.

Salicylic acid is a prime example here.

It physically dissolves the intracellular cement that holds those dead skin scales together, causing them to slough off.

We also use sulfur to promote peeling.

But I'm guessing there's a systemic risk there, too, with salicylic acid.

Always.

At high concentrations over large areas, it can be absorbed and cause salicylism, which is salicylate toxicity that presents as ringing in the ears, hypopnea, and even psychological disturbances.

So we use these peeling agents to treat acne.

But to understand why peeling the skin helps, we really have to look at the pathophysiology of acne itself.

It's not just dirty skin, is it?

Not at all.

It is a biological chain reaction that usually starts during puberty.

First, endrogen hormones spike.

These hormones stimulate the sebaceous glands in the dermis to go into overdrive, producing massive amounts of oily sebum.

So the well starts overflowing.

Right.

Then, all that excess sebum mixes with keratinized cells and physically plugs the pore?

That creates an oxygen -free, nutrient -rich greenhouse underneath the skin.

A greenhouse for what?

For a naturally occurring microbe called propionobacterium acnes, or P.

acnes, it moves in and thrives in that trapped sebum.

The bacteria convert the sebum into highly irritant fatty acids, which triggers a massive immune response.

And boom, you have a painful, inflamed cystic pimple.

So how do we break that chain?

We have to interrupt the cascade.

Non -pharmacologically, that means gentle cleansing, not aggressive scrubbing, which just worsens inflammation.

Pharmacologically, we often start with topical benzoyl peroxide.

Why benzoyl perocto?

What does it actually do to the bacteria?

It's brilliant, actually.

Benzoyl peroxide continuously releases active oxygen into the pore.

Since P.

acnes is an anaerobic bacterium, meaning it thrives without oxygen flooding its environment, with oxygen rapidly suppressing its growth.

Oh, that makes sense.

And crucially, unlike traditional antibiotics, bacteria cannot develop resistance to oxygen, but it can cause peeling.

That's a huge clinical advantage, though.

But what if we need more than just oxygen?

What are the other topical options?

We can use topical antibiotics like quindamycin or erythromycin to directly kill the bacteria, though, you know, resistance is a risk there.

We also rely heavily on retinoids like tretinoin and adipoline.

What are those?

These are vitamin A derivatives.

They work by normalizing the hyperproliferation of those epithelial cells, meaning they tell the skin cells to stop multiplying so fast and to shed normally so the pore never gets plugged in the first place.

Exactly.

They clear the traffic jam.

But for moderate to severe acne, topicals aren't always enough.

We have to use oral antibiotics like doxycycline.

And for the most severe, disfiguring, nodulocystic acne, we escalate to oral isotretinoin.

OK.

I have read the textbook warnings on isotretinoin, and it sounds like a nuclear option.

It causes severe nosebleeds in like 80 percent of patients, massive lip inflammation, elevated triglycerides, muscle pain, and there are warnings for severe depression.

Yes.

The side effect profile is intense.

But most alarming is the taretogenicity.

I mean, it causes devastating birth defects.

It is intensely dangerous to a developing fetus.

That is why the FDA mandates the IPA Legige program.

A patient must have two negative pregnancy tests before starting, commit to using two distinct forms of birth control, and both the prescribing provider and the dispensing pharmacist are heavily tracked to ensure compliance.

Wow, that is strict.

Furthermore, the National Institute for Occupational Safety and Health NAOSH mandates that nurses handle isotretinoin and even topable tretinoin as hazardous drugs.

So if it requires government tracking, strict hazardous handling, and causes all these horrible side effects, it feels like shutting down an entire city's oil refineries just to stop a leaky faucet.

Why do we even use it?

Because of the psychological and physical devastation of severe nodulocystic acne.

We are talking about deep, painful cysts that cause permanent disfiguring, scarring.

The psychological toll on a young adult can be life -altering.

Isotretinoin is unique in pharmacology.

A single, heavily monitored 15 to 20 week course can shrink those sebaceous glands so profoundly that it produces a lifelong, permanent remission of the disease.

The risk is incredibly high, but the therapeutic payoff can literally give a patient their life back.

That really frames the clinical reasoning, it's a calculated risk.

Let's shift gears to a different kind of facial inflammation, rosacea.

How does that differ from acne?

The hallmark difference is that rosacea has no comedones, so no blackheads or whiteheads.

It is primarily a vascular condition characterized by central facial erythema or flushing.

You'll see telangiectasia, which are spider -like dilated blood vessels, and in severe cases rhinofima, which is a bulbous enlargement of the nose.

The textbook mentions newer topical drugs for the redness, specifically alpha -2 agonists like bromonidine and oxymetazoline.

How do those work?

Alpha -2 agonists stimulate receptors on the blood vessels in the skin, causing profound

vasoconstriction.

They literally clamp the blood vessels shut, which temporarily squeezes the redness out of the face.

I looked at the clinical data for these in the text, and it's kind of shocking.

These tiny tubes of cream can cost over $600.

But the efficacy data shows only 12 to 22 % of patients see a substantial improvement.

Yeah, it's not great.

And even worse, when the drug wears off, the blood vessels can rebound and actually make the face redder than before.

You've hit on a critical lesson for evaluating pharmacology.

A drug can have a novel, fascinating mechanism of action -like clamping down specific capillary beds but fail to be a clinical miracle in the real world.

Nurses must evaluate not just how a drug works on paper, but its actual therapeutic value to the patient's daily life.

Speaking of daily life, we have to talk about sunscreens and environmental damage.

The text breaks down ultraviolet radiation into UVA and UVB.

I always forget which does what.

Think of the letters.

UVA penetrates deep into the dermis.

The A stands for aging, allergies, and immunosuppression.

It destroys elastin and collagen over time.

And UVB.

UVB stays shallow in the epidermis.

The B stands for burns.

But remember, both types cause DNA damage, and both types cause skin cancer.

How do the chemical versus physical sunscreens actually stop that DNA damage?

Organic or chemical sunscreens penetrate the stratum corneum slightly.

They absorb the UV radiation on a molecular level and dissipate that dangerous energy harmlessly as heat.

Inorganic or physical sunscreens, like zinc oxide and titanium dioxide, sit right on top of the brick wall and physically scatter and reflect the rays away like a mirror.

When a patient is buying these, they look at the SPF, the sun protection factor.

If a patient upgrades from SPF 15 to SPF 30, they usually assume they're getting double the protection.

But the math of SPF is entirely nonlinear.

SPF is solely an index of protection against UVB rays.

SPF 15 already blocks 93 % of UVB radiation.

SPF 30 blocks 96 .7%.

Oh wow, so it's just a tiny incremental jump, not a doubling of safety.

Exactly.

The true key to protection isn't buying SPF 100.

It's proper application, putting it on 15 minutes before exposure and following the water -resistant rules, which means reapplying every 40 to 80 minutes.

Let's move from environmental DNA damage to a condition where the body's own DNA seems to be stuck on fast -forward.

Psoriasis.

Psoriasis is a chronic autoimmune inflammatory disorder.

The pathophysiology is driven by hyperactive T cells that infiltrate the skin and trigger an intensely accelerated maturation of keratinocytes.

So it's like a factory assembly line with a completely broken off switch.

Exactly.

A normal skin cell takes nearly a month to mature and reach the surface.

In psoriasis, it happens in days.

The cells pile up faster than they can shed, creating thick red plaques covered in silvery stales.

How do you stop that runaway factory line?

For mild cases, we start topically.

We use our high -potency glucocorticoids to suppress the immune response.

We also use vitamin D3 analogs, like calcipotrine, which directly inhibit the proliferation of keratinocytes.

OK, what else?

There's tizaratine, the retinoid we saw in acne, which normalizes cell growth.

We even use older therapies like TARS to suppress DNA synthesis and anthralin.

Anthralin blocks DNA synthesis entirely, though it causes severe chemical irritation and stains basically anything it touches.

But what if the plaques cover a massive portion of the patient's body?

You can't just cover someone in high -potency steroid ointment without risking that adrenal suppression we talked about earlier.

Right.

That's when we transition to conventional systemic drugs.

And these are heavy hitters.

We use methotrexate, which suppresses the hyperactive immune cells.

Wait, methotrexate?

Isn't that a chemotherapy drug used for cancer?

It is.

It is highly cytotoxic.

It requires strict monitoring of liver function and bone marrow suppression.

We also use cyclosporine, which can be nephrotoxic, and acetritin, a systemic retinoid.

And like isotretinoin, I'm assuming it's dangerous for pregnancy.

Profoundly teratogenic.

Patients must enroll in the Do Your PART program to guarantee pregnancy prevention.

The text mentions a really specific warning about alcohol with acetretin.

Yes.

If a patient drinks even a small amount of alcohol, their liver chemically converts the acetretin into a completely different compound called a tretinate.

And why is that bad?

A tretinate has a massive half -life and remains stubbornly trapped in the body's fat cells for years.

A woman wouldn't be able to safely get pregnant for up to three years after her last dose.

The nursing implications for managing psoriasis are just staggering.

You're monitoring liver labs, enforcing hazardous handling protocols, and relentlessly educating on pregnancy.

And that complexity only increases with our systemic biologic options or phototherapy like PUVA, though PUVA is currently limited in the U .S.

Right, the biologics.

Yeah, these are injected drugs like tumor necrosis factor antagonists, adalimumab, atanercept, or infliximab.

We also use interleukin antagonists like usticumab.

They precisely target specific inflammatory pathways.

But by turning off parts of the immune system to heal the skin, you open the door to serious opportunistic infections.

It is the ultimate pharmacological tightrope walk.

Speaking of dangerous cellular growth, let's look at actinic keratosis, or AKs.

These are those rough, scaly patches caused by years of sun damage, and they are precancerous.

Because they can evolve into squamous cell carcinoma, we must eradicate them.

We can use aminoleulinic acid plus blue light or diclofenac, but the primary topical treatment is fluorosil.

Like methotrexate, this is a localized chemotherapy agent.

It works by disrupting DNA and RNA synthesis, targeting rapidly dividing cells.

I have seen patients going through fluorosil treatment.

It is visually shocking.

Their skin turns bright red, violently blisters, and literally slews off.

How does a nurse convince a patient to keep applying a cream that makes their face look and feel like it's melting?

By mastering the art of anticipatory guidance, if a patient isn't warned, they will stop applying the drug on day three out of sheer fear.

A nurse has to explain the why before the treatment even begins.

You tell them that the blistering, the pain, and the tissue disintegration is the visual proof that the drug is successfully seeking out and destroying hidden precancerous cells.

If they understand that the pain is the cure working, they will endure the agonizing two to six week regimen.

That makes total sense.

Now what about atopic dermatitis or severe eczema?

The hallmark there is intense, unbearable itching.

Eczema treatment is a stepwise ladder of risk.

You always start with the safest, thickest moisturizers.

If that fails, you step up to topical steroids.

If inflammation persists, we step up to chrysabrol, a topical PDE4 inhibitor that increases intracellular set gamma P to reduce inflammation.

And if they are still suffering after all that?

We escalate to topical immunosuppressants, specifically calcineurin inhibitors like tacrolimus or pimicrolimus.

But you must educate the patient on the safety alert here.

These carry a rare but severe risk of causing lymphoma and skin cancer.

Sun protection becomes absolutely mandatory.

And the textbook shows that if we have to go systemic for eczema, we use immunomodulators like dupalumab or the new JK inhibitors like avracitinib and hupeydastinib.

But there is a massive black box warning for JK inhibitors, right?

Extremely severe warnings.

JK inhibitors carry risks for serious cardiovascular events, deep vein thrombosis, overwhelming infection and even death.

You are essentially trading intense itching for a small but real risk of fatal complications.

Let's touch quickly on warts, which are caused by the human papillomavirus.

We have the Gardasil vaccine to prevent many strains.

But to treat active warts, the drugs are divided into provider applied and patient applied.

The distinction is vital because of toxicity.

Providers apply caustic resins like podophyllin or TCA and BCA.

Podophyllin halts DNA synthesis and kills the wart.

Crucially though, the provider or patient must wash it off with alcohol or soap just a few hours later.

Why wash it off so fast?

If it sits on the skin too long, it absorbs systemically and causes severe central and peripheral neurotoxicity.

Meanwhile, patient applied drugs for home use are safer, like amikimod, which just stimulates the body's local immune response to fight the virus itself.

Or things like podophyllox and kunecatages.

Moving into our final topics, cosmetic and infectious dermatology.

Even treatments that seem purely aesthetic demand serious pharmacological respect.

Take Botox or onybotulinum toxin A used for frown lines.

How does a toxin smooth out a wrinkle?

It acts on the neuromuscular junction.

It permanently blocks the release of acetylcholine from the nerve terminal.

Without acetylcholine, the muscle physically cannot contract, so the skin above it relaxes.

But there's a warning, isn't there?

Yes, a major black box warning.

If that neurotoxin migrates beyond the injection site, it can paralyze the muscles required for swallowing or breathing, which is obviously life -threatening.

Then we have hair and scalp treatments.

For seborrheic dermatitis, which is driven by malassezia yeast, we use ketoconazole.

But for hair loss, we use topical minoxidil, that is a direct -acting vasodilator.

It increases blood flow to the follicle, though interestingly, it actually causes a shedding phase before new, thicker hair regrows.

Right, and we also use oral finasteride for hair loss, which promotes growth by blocking the enzyme that converts testosterone into its active form, DHT.

But nurses must be hyper -aware of a nursing alert for finasteride, which is… It is highly teratogenic to male fetuses.

Pregnant nurses, or any nurse who might become pregnant, must never handle crushed or broken finasteride pills.

The transdermal absorption of just the dust from a pill can alter fetal development.

Wow, and for unwanted facial hair, there's efflornathine.

Finally, infections.

We deal with fungal tinnia, parasitic lice, and scabies, but the text really emphasizes impetigo.

It's a bacterial infection, mostly staph aureus, famous for presenting as bolus or non -bolus honey -crusted lesions around the mouth.

Yes.

For mild impetigo, reference table 110, point near away, the standard of care is topical mupiricin.

If it progresses to a severe, widespread case, we escalate to oral antibiotics, like cefalexin or clindamycin, to eradicate the staph systemically.

Looking at all these drugs we've covered, I'm noticing a wild pattern here.

Finasteride was originally developed to treat enlarged prostates.

Monoxidil was a systemic blood pressure medication.

Botox is literally derived from one of the deadliest bacterial toxins on earth.

Methotrexate is chemo.

Dermatology feels like the ultimate recycling bin of pharmacology.

It truly is, and that is the biggest takeaway for clinical practice.

Pharmacology is infinitely adaptable, but a drug's mechanism of action doesn't magically change just because you put it in a cream.

A nurse must always remember the systemic origin of a topical drug, because if the skin barrier is compromised, that drug will act systemically.

Which brings us to the finish line of chapter 110.

Safe dermatologic nursing is entirely about respecting the barrier.

It's knowing why an ointment could cause an overdose on a sweaty wound, recognizing the hidden danger of a baby's diaper over a steroid cream, and flawlessly navigating high -stake safety protocols like IPL -DEDGE for isotretinoin.

Thank you for joining this deep dive.

On behalf of the Last Minute Lecture team, thank you for studying with us.

You're going to crush this material.

But before you head into your next shift, consider this.

We spend so much time trying to get drugs through the stratum corneum just to treat local skin diseases.

But as we've seen with the severe systemic toxicity from accidental absorptions, like with steroids and podiphyllin, the skin is actually a remarkably viable doorway straight into the bloodstream.

As formulation technology improves, could the skin eventually replace the GI tract and the IV line as our primary method for delivering life -saving systemic therapies?

Something to think about on your next shift.